The Hunt For Gardasil Adverse Events: A Preview Of Emerging Social Media Challenges
This article was originally published in The Pink Sheet Daily
Bachmann-based brouhaha over Merck's human papilloma virus vaccine underscores the liability risks that firms can face as possible risks for their products are discussed more widely.
You may also be interested in...
Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.
Despite the political noise around the human papillomavirus vaccine, there do not seem to be major new pediatric safety concerns for the Pediatric Advisory Committee to discuss as it reviews Gardasil and 14 other products.
The drug industry has options beyond disappearing from Facebook and missing the opportunities the influential networking site offers.